Stanley Kim
Chief Executive Officer WinSanTor Inc.
Stanley Kim is the CEO and Co-Founder of WinSanTor, a biotechnology company developing the first disease-modifying therapies for peripheral neuropathy. Previously, he co-founded companies acquired by Qualcomm and Apple and developed technologies now standard in most smartphones. He also served as Director of Intellectual Property at The Salk Institute. Stanley earned his degree in Genetics from the University of California, Berkeley, and later transitioned into law and biotechnology
Seminars
Thursday 26th March 2026
The Rationalization of EAPs for Small Biotech
2:15 pm
- Profit, survival or compassionate use • Navigating the evolving Expanded Access Programs globally
- Discussing the “all-in-one” role by managing regulatory, supply, clinical, and commercial responsibilities simultaneously
- Establishing priorities and workflows when multiple functions rely on one or two team members
- Building internal awareness and educating cross-functional teams to secure cooperation and reduce bottlenecks
- Leveraging vendor partnerships strategically to supplement expertise while maintaining oversight
